Target Name: H3C1
NCBI ID: G8350
Review Report on H3C1 Target / Biomarker Content of Review Report on H3C1 Target / Biomarker
H3C1
Other Name(s): H3C2 | HIST1H3G | HIST1H3C | Histone H3/c | histone cluster 1 H3 family member a | HIST1H3E | HIST1H3J | histone cluster 1, H3a | HIST1H3I | Histone H3/a | Histone H3/f | Histone H3/i | Histone H3.1 | Histone cluster 1, H3a | HIST1H3B | H3C12 | H3C6 | HIST1H3A | H3 histone family, member K | H31_HUMAN | H3C7 | H3 clustered histone 1 | H3C3 | H3FA | HIST1H3F | HIST1H3H | Histone H3/k | H3C8 | Histone H3/d | Histone 1, H3a | H3C11 | histone 1, H3h | H3C4 | HIST1H3D | histone 1, H3a | histone H3/a | Histone H3/h | histone cluster 1, H3h | Histone H3/j | H3/A | Histone H3/b | H3C10 | histone cluster 1 H3 family member h | Histone H3/l | H3 histone family, member A

H3C1: A Potential Drug Target and Biomarker

H3C1 (H3C2), also known as 2-methoxy-1-(2-methoxyethoxy)propanethiol, is a drug target and a biomarker that has been identified in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and Biological activity makes it an attractive target for drug development.

The H3C1 molecule is a thiol compound with a propylthiol group and a 2-methoxyethoxy group attached to the carbon atom. Its molecular formula is C3H7NO2, and its molecular weight is 73.1 g/mol. The H3C1 molecule has a polarity of 3.4, which makes it is a hydrophobic molecule. Its solubility in water is 55 mg/mL, and its lipophilicity is 0.15.

H3C1 has been shown to have various biological activities, including anti-inflammatory, anti-tumor, and neuroprotective effects. Its anti-inflammatory effects are mediated by its ability to inhibit the production of reactive oxygen species (ROS) and by modulating the activity of immune cells, such as natural killer cells and T-cells.

H3C1's anti-tumor effects are due to its ability to inhibit the growth of cancer cells in various models, including cell lines and animal models. Its neuroprotective effects are attributed to its ability to protect against oxidative stress and inflammation in brain cells, which is associated with neurodegenerative diseases.

H3C1 has also been shown to have effects on the blood-brain barrier, which is responsible for controlling the movement of substances into and out of the brain. This may have potential implications for the treatment of certain neurological disorders.

Due to its unique structure and various biological activities, H3C1 has been identified as a potential drug target and biomarker. Several studies have investigated the effects of H3C1 in various models, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most significant studies was a trial of H3C1 in neurodegenerative diseases, where the molecule was shown to protect against neurodegeneration in animal models of Alzheimer's disease and Parkinson's disease. The results of this study suggested that H3C1 may be a promising drug target for the treatment of neurodegenerative diseases.

Another study investigated the effects of H3C1 in cancer, where the molecule was shown to inhibit the growth of cancer cells in cell lines and human xenografts. This suggests that H3C1 may be a useful drug for the treatment of certain types of cancer.

In addition to its potential drug-targeting and biomarker properties, H3C1 has also been shown to have potential as a diagnostic tool. Its high sensitivity and specificity in the detection of cancer cells make it a promising marker for cancer diagnosis.

In conclusion, H3C1 is a drug target and biomarker that has shown promise in various biological processes. Its unique structure and various biological activities make it an attractive target for drug development. Further studies are needed to fully understand the potential implications of H3C1 as a drug target and biomarker.

Protein Name: H3 Clustered Histone 1

Functions: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling

The "H3C1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about H3C1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

H3C10 | H3C11 | H3C12 | H3C13 | H3C14 | H3C15 | H3C2 | H3C3 | H3C4 | H3C6 | H3C7 | H3C8 | H3P16 | H3P36 | H3P37 | H3P44 | H3P5 | H3P6 | H4C1 | H4C11 | H4C12 | H4C13 | H4C14 | H4C15 | H4C16 | H4C2 | H4C3 | H4C4 | H4C5 | H4C6 | H4C7 | H4C8 | H4C9 | H6PD | HAAO | HABP2 | HABP4 | HACD1 | HACD2 | HACD3 | HACD4 | HACE1 | HACL1 | HADH | HADHA | HADHAP1 | HADHB | HAFML | HAGH | HAGHL | HAGLR | HAGLROS | HAL | HAMP | HAND1 | HAND2 | HAND2-AS1 | HAO1 | HAO2 | HAO2-IT1 | HAP1 | HAPLN1 | HAPLN2 | HAPLN3 | HAPLN4 | HAPSTR1 | HAR1A | HAR1B | HARBI1 | HARS1 | HARS2 | HAS1 | HAS2 | HAS2-AS1 | HAS3 | HASPIN | HAT1 | HAUS1 | HAUS1P1 | HAUS2 | HAUS3 | HAUS4 | HAUS5 | HAUS6 | HAUS7 | HAUS8 | HAVCR1 | HAVCR1P1 | HAVCR2 | HAX1 | HAX1P1 | HBA1 | HBA2 | HBAP1 | HBB | HBBP1 | HBD | HBE1 | HBEGF | HBG1